Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV000422832 | SCV000524026 | uncertain significance | not provided | 2017-01-16 | criteria provided, single submitter | clinical testing | The c.1858-11 C>A variant of uncertain significance in the LDB3 gene has not been published as a pathogenic variant or been reported as a benign variant to our knowledge. This variant was not observed with any significant frequency in approximately 6,500 individuals of European and African American ancestry in the NHLBI Exome Sequencing Project, and was not observed in the Exome Aggregation Consortium, indicating it is not a common benign variant in these populations. The c.1858-11 C>A variant is predicted to impact the natural splice acceptor site in intron 10; however, in the absence of functional mRNA studies, the physiological consequence of this variant on splicing cannot be precisely determined. Furthermore, no other splice site variants in the LDB3 gene have been reported in the Human Gene Mutation Database in association with cardiomyopathy (Stenson et al., 2014). |
Fulgent Genetics, |
RCV002502532 | SCV002812812 | uncertain significance | Dilated cardiomyopathy 1C; Myofibrillar myopathy 4 | 2021-08-23 | criteria provided, single submitter | clinical testing |